Henrik Stenqvist

Henrik Stenqvist is a declared insider of Swedish Orphan Biovitrum AB (publ) (finance chief), with filings sourced from Finansinspektionen. In total, 21 filings cover trades dated from 14 November 2018 to 22 July 2026.

Both buying and selling appear: 7 purchases worth €6.6M, against 5 sales worth €10.2M. Netting one side against the other leaves €3.6M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 6 share grants. Since January 2026: 1 purchase and 1 sale on the market.

Half of the purchases are above €1.2M and half below. 6 out of 7 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 22 July 2026, reports an open-market purchase of €1.2M in Swedish Orphan Biovitrum AB (publ). Typically, a trade is published a median of 1 day after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.